The Asia Pacific Glutamic Acid Market would witness market growth of 5.5% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 1,605.26 Kilo Tonnes, showcasing a growth of 4.6% (2019-2022).
The market stands at the intersection of the food and pharmaceutical industries, pivotal in enhancing flavors, nutrition, and various biochemical processes. As a non-essential amino acid, it is a fundamental building block for proteins, but its significance goes beyond basic nutrition. In addition, the versatility of it extends far beyond its role as a fundamental building block for proteins. It has found application in numerous sectors, such as pharmaceuticals, food, and industrial operations. The adoption of the acid is driven by its capacity to elevate sensory experiences, improve product formulations, and contribute to advancements in biochemical and pharmaceutical fields.
Moreover, in industrial settings, this catalyzes biochemical innovation. Its application in producing biochemicals, biofuels, and other industrial compounds demonstrates its versatility beyond food and pharmaceuticals. Biotechnological advancements, including genetically modified microorganisms and fermentation processes, have enhanced the efficiency and sustainability of this acid production for industrial applications. As industries explore more sustainable and eco-friendly practices, adopting glutamic acid as a biochemical precursor aligns with the push towards green technologies. As a key component in fermentation processes, it contributes to developing sustainable bioenergy solutions, offering an alternative to traditional fossil fuels.
South Korean cosmetic companies are known for innovating and using advanced technologies in product development. India has a rapidly growing pharmaceutical industry known for its generic drug manufacturing capabilities. As per the data released in 2023 by the India Brand Equity Foundation, it is expected that the Indian pharmaceuticals sector will attain a value of US$65 billion by 2024 and US$130 billion by 2030. The Indian pharmaceutical industry is estimated to be worth around $50 billion, of which more than $25 billion is derived from exports, according to government data. Therefore, the growing pharmaceutical and cosmetics sectors in the Asia Pacific will drive the demand for the acid in the region.
The China market dominated the Asia Pacific Glutamic Acid Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,731.3 million by 2030. The Japan market is registering a CAGR of 4.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.1% during (2023 - 2030).
Free Valuable Insights: The Global Glutamic Acid Market is Predict to reach USD 16.3 Billion by 2030, at a CAGR of 5.1%
Based on End-use, the market is segmented into Food Industry, Pharmaceutical, Cosmetic & Personal Care, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By End-use (Volume, Kilo Tonnes, USD Billion, 2019-2030)
By Country (Volume, Kilo Tonnes, USD Billion, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
